14 April 2021, Munich - Epilepsy is one of the most common serious neurological disorders with around 50 million people living with this diagnosis. One key medication to treat epilepsy is levetiracetam...
02 February 2021, Munich - In spring 2020, when the corona pandemic started spreading around the globe, many efforts were made to treat infected patients with existing drugs. Especially paracetamol made headlines due to recommendations by several governments and the World Health Organization.
04 November 2020, Munich - Macrolides and cephalosporins are some of the most commonly used antibiotics. During the CoViD‐19 crisis, several
of these APIs like azithromycin and cefuroxime turned out to be effective in the treatment of patients infected with CoViD‐19...
22 September 2020, Munich - Losartan API prices tripled in a very short period while it was considered as a potential CoViD-19 remedy earlier this year. Other related substances have fared rather stable throughout the crisis, and one well-known “sartan” never recovered from its NDMA scandal in 2018...
20 August 2020, Munich - Prices for penicillins increased by 14-20 % during the first half of 2020 with prices for some penicillin APIs “shooting up” more than 40 %. Governments worldwide have undertaken efforts to decrease reliance on API imports from Asia...
18 June 2020, Munich - British scientists from Oxford University published a study about Dexamethasone demonstrating positive effects on patients requiring ventilation due to a corona infection...
14 May 2020, Munich - Primarily driven by lower prices for APIs manufacturing has mainly moved to India and China. The corona crisis could become a turning point for the pharmaceutical industry...
29 April 2020, Munich - Shortly after the outbreak of the corona crisis, scientists started to test existing drugs as potential remedies. Two malaria drugs received particular attention and widespread media coverage...
